<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0008643'>Nephroblastomatosis</z:hpo> is a complex of pathological conditions defined by the persistence of nephrogenic elements after the conclusion of nephrogenesis (beyond week 36 of gestation) that conserve the capacity to evolve into <z:hpo ids='HP_0002667'>nephroblastoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Luckily, this <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> is exceptional (&lt; 1%(1)), which is why the disease is considered to have a good prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>The nephrogenic remains are frequently associated with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">beckwith-Wiedemann syndrome</z:e>, <z:hpo ids='HP_0001528'>hemihypertrophy</z:hpo> and <z:hpo ids='HP_0000526'>aniridia</z:hpo>, in which case there is a greater risk of the development of <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Consequently, these children must be followed-up closely </plain></SENT>
<SENT sid="4" pm="."><plain>The difficulty lay in knowing when to act, which children should be treated, and what treatment is appropriate because what little has been published in the literature is debatable </plain></SENT>
<SENT sid="5" pm="."><plain>We report the cases of two patients, one with unilateral <z:hpo ids='HP_0008643'>nephroblastomatosis</z:hpo> and the other bilateral, who required surgical treatment after not responding to chemotherapy; and we expose our therapeutic algorithm and follow-up strategy </plain></SENT>
</text></document>